Guest Editorial New leadership, vision for the Worldwide Innovative Network Consortium in precision oncology December 08, 2023Vol.49 No.45By Wafik S. El-Deiry
Guest Editorial Turning the page: Projections for cancer care in the coming year December 08, 2023Vol.49 No.45By Samyukta Mullangi
Guest Editorial For cancer patients, traditional Medicare is better than Medicare Advantage December 01, 2023Vol.49 No.44By Hagop M. Kantarjian and Mary Alma Welch
Guest Editorial Integrating cancer care: the Advocate Health experience November 17, 2023Vol.49 No.43By Ruben A. Mesa and James L. Weese
Guest Editorial Liquid biopsy cancer screening: We’ll need more than one size to fit all November 17, 2023Vol.49 No.43By Peter B. Bach
Guest Editorial Patients are the key to disruptive innovation in cancer. Why aren’t they at the table? November 10, 2023Vol.49 No.42By Jenny Ahlstrom
Guest Editorial ACS expands lung cancer screening eligibility to ages 50-80 with 20+ pack-yearsPrevious guideline was 55-74 with 30+ pack years November 03, 2023Vol.49 No.41By Robert A. Smith and William L. Dahut
Guest Editorial “Oppenheimer” is a reminder to physicians, scientists to act to prevent nuclear war September 29, 2023Vol.49 No.36By Robert Peter Gale and Andreas Hochhaus
FreeGuest Editorial The insinuation that AstroTurf causes GBM has no basis in scienceThe Philadelphia Inquirer series does disservice to brain tumor community September 15, 2023Vol.49 No.34By Henry S. Friedman and Kyle M. Walsh
Guest Editorial What’s the right dose of sotorasib? Is it 240 mg qd or 4x that?The Oct. 5 ODAC will be a nailbiter September 08, 2023Vol.49 No.33By Mark J. Ratain
